110915 ⎘
ssRNA viruses negative-sense; Details; Paramyxoviridae; Henipavirus, e.g. hendra virus New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
METHODS FOR ASSEMBLING PROTEIN-CONJUGATED NANOCARRIER VACCINES
#2STABILIZED TRIMERIC CLASS I FUSION PROTEINS
#3FUSOSOME COMPOSITIONS AND USES THEREOF
#4CD4-SPECIFIC ANTIBODY CONSTRUCTS AND COMPOSITIONS AND USES THEREOF
#5RECOMBINANT CEDAR VIRUS CHIMERAS
#6PARAMYXOVIRUS VIRUS-LIKE PARTICLES AS PROTEIN DELIVERY VEHICLES
#7CYTOKINE RECEPTOR AGONIST AND VIRAL VECTOR COMBINATION THERAPIES
#8TARGETED DELIVERY OF ARMMS
#9Rapid Acting Vaccine Against Nipah Virus
#10HENIPAVIRUS VACCINE
#11METHODS AND SYSTEMS OF PARTICLE PRODUCTION
#12MODIFIED PARAMYXOVIRIDAE FUSION GLYCOPROTEINS
#13ENGINEERED VIRAL PARTICLES AND USES OF THE SAME
#14MODIFIED PARAMYXOVIRIDAE ATTACHMENT GLYCOPROTEINS
#15STRUCTURES OF LANGYA VIRUS FUSION PROTEIN ECTODOMAIN AND IMMUNOGENIC COMPOSITIONS DERIVED THEREFROM
#16USE OF CD4-TARGETED VIRAL VECTORS
#17METHODS AND COMPOSITIONS FOR PRODUCING VIRAL FUSOSOMES
#18METHODS FOR SELECTIVELY MODULATING THE ACTIVITY OF DISTINCT SUBTYPES OF CELLS
#19NIPAH VIRUS ENVELOPE PSEUDOTYPED LENTIVIRUSES AND METHODS OF THEIR USE
#20Henipavirus vaccine
#21CD8-specific antibody constructs and compositions thereof
#22Paramyxovirus virus-like particles as protein delivery vehicles
#23PARAMYXOVIRUS VIRUS-LIKE PARTICLES AS PROTEIN DELIVERY VEHICLES
#24TARGETED LIPID PARTICLES AND COMPOSITIONS AND USES THEREOF
#25Nipah virus immunogens and their use
#26VACCINES AGAINST NIPAH VIRUS, AND METHODS OF USING SAME
#27FUSOSOME COMPOSITIONS AND USES THEREOF
#28Immunogenic Cedar Virus compositions
#29Henipavirus vaccine
#30Paramyxovirus virus-like particles as protein delivery vehicles
#31Nipah virus envelope glycoprotein pseudotyped lentivirus
#32Nipah virus envelope pseudotyped lentiviruses and methods of their use
#33HENDRA AND NIPAH VIRUS G GLYCOPROTEIN IMMUNOGENIC COMPOSITIONS
#34Soluble forms of Hendra and Nipah virus F glycoprotein and uses thereof
#35Soluble Forms of Hendra and Nipah Virus G Glycoprotein
#36Tunable vaccine platform against pathogens of the paramyxovirus family
#37Nipah virus envelope pseudotyped lentiviruses and methods of their use
#38Paramyxovirus virus-like particles as protein delivery vehicles
#39Soluble forms of Hendra and Nipah virus G glycoprotein
#40Peptides including a binding domain of the viral phosphoprotein (P) subunit to the viral RNA free nucleoprotein (N)
#41Hendra virus recombinant compositions and uses thereof
#42Cedar virus and methods of use
#43Soluble forms of hendra and nipah virus G glycoprotein
#44Nipah virus envelope pseudotyped lentiviruses and methods of their use
#45Soluble forms of Hendra and Nipah virus G glycoprotein
#46Soluble forms of hendra and nipah virus G glycoprotein
#47HENDRA VIRUS RECOMBINANT COMPOSITIONS AND USES THEREOF
#48Soluble forms of Hendra and Nipah virus F glycoprotein and uses thereof
#49Nipah virus vaccines
#50Composition and methods for the inhibition of membrane fusion by paramyxoviruses
#51Soluble forms of Hendra and Nipah virus G glycoprotein
#52Use of ephrinb2 directed agents for the treatment or prevention of viral infections
#53Method for detecting Nipah virus and method for providing immunoprotection against Henipa viruses
#54Nipah virus vaccines
#55Compositions and methods for the inhibition of membrane fusion by paramyxoviruses
#56Method for detecting Nipah virus and method for providing immunoprotection against Henipa viruses